+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomedical Materials Market in the US 2025-2029

  • PDF Icon

    Report

  • 170 Pages
  • March 2025
  • Region: United States
  • TechNavio
  • ID: 6091503
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biomedical materials market in the US is forecasted to grow by USD 4.61 billion during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the biomedical materials market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by aging population, expanding regenerative medicine and tissue engineering, and rising prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The biomedical materials market in the US is segmented as below:

By Type

  • Metallic
  • Polymers
  • Ceramic
  • Natural

By Application

  • Orthopedic
  • Cardiovascular
  • Dental
  • Neurology
  • Others

By Geographical Landscape

  • North America
This study identifies the adoption of 3D-printable biomaterials as one of the prime reasons driving the biomedical materials market in the US growth during the next few years. Also, development of bioresorbable materials and incorporation of nanotechnology will lead to sizable demand in the market.

The report on the biomedical materials market in the US covers the following areas:

  • Biomedical Materials Market in the US sizing
  • Biomedical Materials Market in the US forecast
  • Biomedical Materials Market in the US industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biomedical materials market in the US vendors that include 3D Systems Corp., Allegheny Technologies Inc., BASF SE, Berkeley Advanced Biomaterials, Biomaterial USA LLC, Carpenter Technology Corp., Celanese Corp., ConvaTec Group PLC, CoorsTek Inc., Corbion nv, Covation Biomaterials LLC, Covestro AG, DSM-Firmenich AG, Evonik Industries AG, Hollister Inc., Integra LifeSciences Holdings Corp., KYOCERA Corp., Morgan Advanced Materials PLC, Regenity, and Smith and Nephew PLC. Also, the biomedical materials market in the US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US: Year-over-year growth 2024-2029 (%)
Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Biomedical Materials Market in US 2019 - 2023
Historic Market Size - Data Table on Biomedical Materials Market in US 2019 - 2023 ($ billion)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.3 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on Biomedical Materials Market in US
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Metallic - Market size and forecast 2024-2029
Chart on Metallic - Market size and forecast 2024-2029 ($ billion)
Data Table on Metallic - Market size and forecast 2024-2029 ($ billion)
Chart on Metallic - Year-over-year growth 2024-2029 (%)
Data Table on Metallic - Year-over-year growth 2024-2029 (%)
8.4 Polymers - Market size and forecast 2024-2029
Chart on Polymers - Market size and forecast 2024-2029 ($ billion)
Data Table on Polymers - Market size and forecast 2024-2029 ($ billion)
Chart on Polymers - Year-over-year growth 2024-2029 (%)
Data Table on Polymers - Year-over-year growth 2024-2029 (%)
8.5 Ceramic - Market size and forecast 2024-2029
Chart on Ceramic - Market size and forecast 2024-2029 ($ billion)
Data Table on Ceramic - Market size and forecast 2024-2029 ($ billion)
Chart on Ceramic - Year-over-year growth 2024-2029 (%)
Data Table on Ceramic - Year-over-year growth 2024-2029 (%)
8.6 Natural - Market size and forecast 2024-2029
Chart on Natural - Market size and forecast 2024-2029 ($ billion)
Data Table on Natural - Market size and forecast 2024-2029 ($ billion)
Chart on Natural - Year-over-year growth 2024-2029 (%)
Data Table on Natural - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by Application
9.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
9.3 Orthopedic - Market size and forecast 2024-2029
Chart on Orthopedic - Market size and forecast 2024-2029 ($ billion)
Data Table on Orthopedic - Market size and forecast 2024-2029 ($ billion)
Chart on Orthopedic - Year-over-year growth 2024-2029 (%)
Data Table on Orthopedic - Year-over-year growth 2024-2029 (%)
9.4 Cardiovascular - Market size and forecast 2024-2029
Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
9.5 Dental - Market size and forecast 2024-2029
Chart on Dental - Market size and forecast 2024-2029 ($ billion)
Data Table on Dental - Market size and forecast 2024-2029 ($ billion)
Chart on Dental - Year-over-year growth 2024-2029 (%)
Data Table on Dental - Year-over-year growth 2024-2029 (%)
9.6 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
11.4 Market opportunities/restraints
12 Competitive Landscape
12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business
13 Competitive Analysis
13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 Allegheny Technologies Inc.
Allegheny Technologies Inc. - Overview
Allegheny Technologies Inc. - Business segments
Allegheny Technologies Inc. - Key offerings
Allegheny Technologies Inc. - Segment focus
SWOT
13.5 BASF SE
BASF SE - Overview
BASF SE - Business segments
BASF SE - Key news
BASF SE - Key offerings
BASF SE - Segment focus
SWOT
13.6 Berkeley Advanced Biomaterials
Berkeley Advanced Biomaterials - Overview
Berkeley Advanced Biomaterials - Product / Service
Berkeley Advanced Biomaterials - Key offerings
SWOT
13.7 Carpenter Technology Corp.
Carpenter Technology Corp. - Overview
Carpenter Technology Corp. - Business segments
Carpenter Technology Corp. - Key offerings
Carpenter Technology Corp. - Segment focus
SWOT
13.8 Celanese Corp.
Celanese Corp. - Overview
Celanese Corp. - Business segments
Celanese Corp. - Key news
Celanese Corp. - Key offerings
Celanese Corp. - Segment focus
SWOT
13.9 ConvaTec Group Plc
ConvaTec Group Plc - Overview
ConvaTec Group Plc - Product / Service
ConvaTec Group Plc - Key offerings
SWOT
13.10 CoorsTek Inc.
CoorsTek Inc. - Overview
CoorsTek Inc. - Product / Service
CoorsTek Inc. - Key offerings
SWOT
13.11 Corbion nv
Corbion nv - Overview
Corbion nv - Business segments
Corbion nv - Key news
Corbion nv - Key offerings
Corbion nv - Segment focus
SWOT
13.12 Covestro AG
Covestro AG - Overview
Covestro AG - Business segments
Covestro AG - Key news
Covestro AG - Key offerings
Covestro AG - Segment focus
SWOT
13.13 DSM-Firmenich AG
DSM-Firmenich AG - Overview
DSM-Firmenich AG - Product / Service
DSM-Firmenich AG - Key offerings
SWOT
13.14 Evonik Industries AG
Evonik Industries AG - Overview
Evonik Industries AG - Business segments
Evonik Industries AG - Key news
Evonik Industries AG - Key offerings
Evonik Industries AG - Segment focus
SWOT
13.15 Hollister Inc.
Hollister Inc. - Overview
Hollister Inc. - Product / Service
Hollister Inc. - Key offerings
SWOT
13.16 Integra LifeSciences Holdings Corp.
Integra LifeSciences Holdings Corp. - Overview
Integra LifeSciences Holdings Corp. - Business segments
Integra LifeSciences Holdings Corp. - Key news
Integra LifeSciences Holdings Corp. - Key offerings
Integra LifeSciences Holdings Corp. - Segment focus
SWOT
13.17 KYOCERA Corp.
KYOCERA Corp. - Overview
KYOCERA Corp. - Business segments
KYOCERA Corp. - Key news
KYOCERA Corp. - Key offerings
KYOCERA Corp. - Segment focus
SWOT
13.18 Regenity
Regenity - Overview
Regenity - Product / Service
Regenity - Key offerings
SWOT
14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Type
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Company Market Positioning
Exhibits 7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 8: Overview on criticality of inputs and factors of differentiation
Exhibits 9: Overview on factors of disruption
Exhibits 10: Impact of drivers and challenges in 2024 and 2029
Exhibits 11: Parent Market
Exhibits 12: Data Table on - Parent Market
Exhibits 13: Market characteristics analysis
Exhibits 14: Value chain analysis
Exhibits 15: Offerings of companies included in the market definition
Exhibits 16: Market segments
Exhibits 17: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 18: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 19: Chart on US: Year-over-year growth 2024-2029 (%)
Exhibits 20: Data Table on US: Year-over-year growth 2024-2029 (%)
Exhibits 21: Historic Market Size - Data Table on Biomedical Materials Market in US 2019 - 2023 ($ billion)
Exhibits 22: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits 23: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits 24: Five forces analysis - Comparison between 2024 and 2029
Exhibits 25: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 27: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 28: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 29: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 30: Chart on Market condition - Five forces 2024 and 2029
Exhibits 31: Chart on Type - Market share 2024-2029 (%)
Exhibits 32: Data Table on Type - Market share 2024-2029 (%)
Exhibits 33: Chart on Comparison by Type
Exhibits 34: Data Table on Comparison by Type
Exhibits 35: Chart on Metallic - Market size and forecast 2024-2029 ($ billion)
Exhibits 36: Data Table on Metallic - Market size and forecast 2024-2029 ($ billion)
Exhibits 37: Chart on Metallic - Year-over-year growth 2024-2029 (%)
Exhibits 38: Data Table on Metallic - Year-over-year growth 2024-2029 (%)
Exhibits 39: Chart on Polymers - Market size and forecast 2024-2029 ($ billion)
Exhibits 40: Data Table on Polymers - Market size and forecast 2024-2029 ($ billion)
Exhibits 41: Chart on Polymers - Year-over-year growth 2024-2029 (%)
Exhibits 42: Data Table on Polymers - Year-over-year growth 2024-2029 (%)
Exhibits 43: Chart on Ceramic - Market size and forecast 2024-2029 ($ billion)
Exhibits 44: Data Table on Ceramic - Market size and forecast 2024-2029 ($ billion)
Exhibits 45: Chart on Ceramic - Year-over-year growth 2024-2029 (%)
Exhibits 46: Data Table on Ceramic - Year-over-year growth 2024-2029 (%)
Exhibits 47: Chart on Natural - Market size and forecast 2024-2029 ($ billion)
Exhibits 48: Data Table on Natural - Market size and forecast 2024-2029 ($ billion)
Exhibits 49: Chart on Natural - Year-over-year growth 2024-2029 (%)
Exhibits 50: Data Table on Natural - Year-over-year growth 2024-2029 (%)
Exhibits 51: Market opportunity by Type ($ billion)
Exhibits 52: Data Table on Market opportunity by Type ($ billion)
Exhibits 53: Chart on Application - Market share 2024-2029 (%)
Exhibits 54: Data Table on Application - Market share 2024-2029 (%)
Exhibits 55: Chart on Comparison by Application
Exhibits 56: Data Table on Comparison by Application
Exhibits 57: Chart on Orthopedic - Market size and forecast 2024-2029 ($ billion)
Exhibits 58: Data Table on Orthopedic - Market size and forecast 2024-2029 ($ billion)
Exhibits 59: Chart on Orthopedic - Year-over-year growth 2024-2029 (%)
Exhibits 60: Data Table on Orthopedic - Year-over-year growth 2024-2029 (%)
Exhibits 61: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Exhibits 62: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ billion)
Exhibits 63: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 64: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%)
Exhibits 65: Chart on Dental - Market size and forecast 2024-2029 ($ billion)
Exhibits 66: Data Table on Dental - Market size and forecast 2024-2029 ($ billion)
Exhibits 67: Chart on Dental - Year-over-year growth 2024-2029 (%)
Exhibits 68: Data Table on Dental - Year-over-year growth 2024-2029 (%)
Exhibits 69: Chart on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Data Table on Neurology - Market size and forecast 2024-2029 ($ billion)
Exhibits 71: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 72: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 73: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 74: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 75: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 76: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 77: Market opportunity by Application ($ billion)
Exhibits 78: Data Table on Market opportunity by Application ($ billion)
Exhibits 79: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 80: Impact of drivers and challenges in 2024 and 2029
Exhibits 81: Overview on criticality of inputs and factors of differentiation
Exhibits 82: Overview on factors of disruption
Exhibits 83: Impact of key risks on business
Exhibits 84: Companies covered
Exhibits 85: Company ranking index
Exhibits 86: Matrix on companies position and classification
Exhibits 87: Allegheny Technologies Inc. - Overview
Exhibits 88: Allegheny Technologies Inc. - Business segments
Exhibits 89: Allegheny Technologies Inc. - Key offerings
Exhibits 90: Allegheny Technologies Inc. - Segment focus
Exhibits 91: SWOT
Exhibits 92: BASF SE - Overview
Exhibits 93: BASF SE - Business segments
Exhibits 94: BASF SE - Key news
Exhibits 95: BASF SE - Key offerings
Exhibits 96: BASF SE - Segment focus
Exhibits 97: SWOT
Exhibits 98: Berkeley Advanced Biomaterials - Overview
Exhibits 99: Berkeley Advanced Biomaterials - Product / Service
Exhibits 100: Berkeley Advanced Biomaterials - Key offerings
Exhibits 101: SWOT
Exhibits 102: Carpenter Technology Corp. - Overview
Exhibits 103: Carpenter Technology Corp. - Business segments
Exhibits 104: Carpenter Technology Corp. - Key offerings
Exhibits 105: Carpenter Technology Corp. - Segment focus
Exhibits 106: SWOT
Exhibits 107: Celanese Corp. - Overview
Exhibits 108: Celanese Corp. - Business segments
Exhibits 109: Celanese Corp. - Key news
Exhibits 110: Celanese Corp. - Key offerings
Exhibits 111: Celanese Corp. - Segment focus
Exhibits 112: SWOT
Exhibits 113: ConvaTec Group Plc - Overview
Exhibits 114: ConvaTec Group Plc - Product / Service
Exhibits 115: ConvaTec Group Plc - Key offerings
Exhibits 116: SWOT
Exhibits 117: CoorsTek Inc. - Overview
Exhibits 118: CoorsTek Inc. - Product / Service
Exhibits 119: CoorsTek Inc. - Key offerings
Exhibits 120: SWOT
Exhibits 121: Corbion nv - Overview
Exhibits 122: Corbion nv - Business segments
Exhibits 123: Corbion nv - Key news
Exhibits 124: Corbion nv - Key offerings
Exhibits 125: Corbion nv - Segment focus
Exhibits 126: SWOT
Exhibits 127: Covestro AG - Overview
Exhibits 128: Covestro AG - Business segments
Exhibits 129: Covestro AG - Key news
Exhibits 130: Covestro AG - Key offerings
Exhibits 131: Covestro AG - Segment focus
Exhibits 132: SWOT
Exhibits 133: DSM-Firmenich AG - Overview
Exhibits 134: DSM-Firmenich AG - Product / Service
Exhibits 135: DSM-Firmenich AG - Key offerings
Exhibits 136: SWOT
Exhibits 137: Evonik Industries AG - Overview
Exhibits 138: Evonik Industries AG - Business segments
Exhibits 139: Evonik Industries AG - Key news
Exhibits 140: Evonik Industries AG - Key offerings
Exhibits 141: Evonik Industries AG - Segment focus
Exhibits 142: SWOT
Exhibits 143: Hollister Inc. - Overview
Exhibits 144: Hollister Inc. - Product / Service
Exhibits 145: Hollister Inc. - Key offerings
Exhibits 146: SWOT
Exhibits 147: Integra LifeSciences Holdings Corp. - Overview
Exhibits 148: Integra LifeSciences Holdings Corp. - Business segments
Exhibits 149: Integra LifeSciences Holdings Corp. - Key news
Exhibits 150: Integra LifeSciences Holdings Corp. - Key offerings
Exhibits 151: Integra LifeSciences Holdings Corp. - Segment focus
Exhibits 152: SWOT
Exhibits 153: KYOCERA Corp. - Overview
Exhibits 154: KYOCERA Corp. - Business segments
Exhibits 155: KYOCERA Corp. - Key news
Exhibits 156: KYOCERA Corp. - Key offerings
Exhibits 157: KYOCERA Corp. - Segment focus
Exhibits 158: SWOT
Exhibits 159: Regenity - Overview
Exhibits 160: Regenity - Product / Service
Exhibits 161: Regenity - Key offerings
Exhibits 162: SWOT
Exhibits 163: Inclusions checklist
Exhibits 164: Exclusions checklist
Exhibits 165: Currency conversion rates for US$
Exhibits 166: Research methodology
Exhibits 167: Information sources
Exhibits 168: Data validation
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Data synthesis
Exhibits 171: 360 degree market analysis
Exhibits 172: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the biomedical materials market in us: 3D Systems Corp., Allegheny Technologies Inc., BASF SE, Berkeley Advanced Biomaterials, Biomaterial USA LLC, Carpenter Technology Corp., Celanese Corp., ConvaTec Group Plc, CoorsTek Inc., Corbion nv, Covation Biomaterials LLC, Covestro AG, DSM-Firmenich AG, Evonik Industries AG, Hollister Inc., Integra LifeSciences Holdings Corp., KYOCERA Corp., Morgan Advanced Materials Plc, Regenity, and Smith and Nephew plc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is adoption of 3d-printable biomaterials."

According to the report, one of the major drivers for this market is the aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Systems Corp.
  • Allegheny Technologies Inc.
  • BASF SE
  • Berkeley Advanced Biomaterials
  • Biomaterial USA LLC
  • Carpenter Technology Corp.
  • Celanese Corp.
  • ConvaTec Group Plc
  • CoorsTek Inc.
  • Corbion nv
  • Covation Biomaterials LLC
  • Covestro AG
  • DSM-Firmenich AG
  • Evonik Industries AG
  • Hollister Inc.
  • Integra LifeSciences Holdings Corp.
  • KYOCERA Corp.
  • Morgan Advanced Materials Plc
  • Regenity
  • Smith and Nephew plc